Agilent Technologies, Inc. $A Holdings Lowered by The Manufacturers Life Insurance Company

The Manufacturers Life Insurance Company reduced its stake in Agilent Technologies, Inc. (NYSE:A) by 8.0% in the first quarter, HoldingsChannel reports. The fund owned 149,370 shares of the medical research company’s stock after selling 13,025 shares during the quarter. The Manufacturers Life Insurance Company’s holdings in Agilent Technologies were worth $17,025,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also made changes to their positions in A. Massachusetts Financial Services Co. MA lifted its position in Agilent Technologies by 13.8% in the fourth quarter. Massachusetts Financial Services Co. MA now owns 14,147,601 shares of the medical research company’s stock worth $1,925,064,000 after purchasing an additional 1,713,216 shares during the period. State Street Corp increased its position in shares of Agilent Technologies by 1.9% during the 4th quarter. State Street Corp now owns 12,681,792 shares of the medical research company’s stock valued at $1,725,611,000 after purchasing an additional 241,029 shares during the period. Geode Capital Management LLC raised its stake in shares of Agilent Technologies by 0.3% in the 4th quarter. Geode Capital Management LLC now owns 7,425,861 shares of the medical research company’s stock worth $1,006,519,000 after buying an additional 25,139 shares in the last quarter. Morgan Stanley raised its stake in shares of Agilent Technologies by 15.9% in the 4th quarter. Morgan Stanley now owns 5,041,881 shares of the medical research company’s stock worth $686,049,000 after buying an additional 692,202 shares in the last quarter. Finally, Norges Bank acquired a new stake in shares of Agilent Technologies in the fourth quarter valued at $549,158,000.

Analyst Ratings Changes

A has been the subject of several research reports. Barclays raised their target price on Agilent Technologies from $145.00 to $150.00 and gave the company an “overweight” rating in a research note on Wednesday, June 24th. Weiss Ratings raised shares of Agilent Technologies from a “hold (c-)” rating to a “hold (c)” rating in a report on Tuesday, June 2nd. Robert W. Baird raised their price objective on shares of Agilent Technologies from $155.00 to $156.00 and gave the company an “outperform” rating in a research report on Tuesday, May 26th. Jefferies Financial Group assumed coverage on shares of Agilent Technologies in a research note on Thursday, July 9th. They issued a “hold” rating and a $135.00 price objective on the stock. Finally, Wells Fargo & Company dropped their target price on shares of Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating on the stock in a report on Thursday, May 28th. Two investment analysts have rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and four have assigned a Hold rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $159.35.

Agilent Technologies Stock Down 0.3%

Shares of Agilent Technologies stock opened at $138.32 on Friday. The stock’s fifty day moving average is $132.35 and its 200-day moving average is $125.30. The firm has a market capitalization of $39.06 billion, a PE ratio of 27.77, a price-to-earnings-growth ratio of 2.46 and a beta of 1.25. The company has a quick ratio of 1.62, a current ratio of 2.10 and a debt-to-equity ratio of 0.43. Agilent Technologies, Inc. has a 12-month low of $108.35 and a 12-month high of $160.27.

Agilent Technologies (NYSE:A) last announced its earnings results on Wednesday, May 27th. The medical research company reported $1.49 EPS for the quarter, beating the consensus estimate of $1.41 by $0.08. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.The business had revenue of $1.83 billion during the quarter, compared to the consensus estimate of $1.80 billion. During the same period in the prior year, the business posted $1.31 earnings per share. Agilent Technologies’s revenue was up 10.0% compared to the same quarter last year. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. Equities analysts anticipate that Agilent Technologies, Inc. will post 6.01 earnings per share for the current year.

Agilent Technologies Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, July 22nd. Shareholders of record on Tuesday, June 30th were paid a dividend of $0.255 per share. The ex-dividend date of this dividend was Tuesday, June 30th. This represents a $1.02 dividend on an annualized basis and a yield of 0.7%. Agilent Technologies’s dividend payout ratio is currently 20.48%.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.